Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Immune-modulating and anti-inflammatory marine compounds against cancer.

Florean C, Dicato M, Diederich M.

Semin Cancer Biol. 2020 Feb 15. pii: S1044-579X(20)30041-9. doi: 10.1016/j.semcancer.2020.02.008. [Epub ahead of print] Review.

PMID:
32070764
2.

Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia.

Song S, Lee JY, Ermolenko L, Mazumder A, Ji S, Ryu H, Kim H, Kim DW, Lee JW, Dicato M, Christov C, Schnekenburger M, Cerella C, Gérard D, Orlikova-Boyer B, Al-Mourabit A, Diederich M.

Cell Death Dis. 2020 Feb 7;11(2):109. doi: 10.1038/s41419-020-2304-8.

3.

HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?

Losson H, Schnekenburger M, Dicato M, Diederich M.

Cancers (Basel). 2020 Jan 29;12(2). pii: E318. doi: 10.3390/cancers12020318. Review.

4.

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis.

Battistelli C, Diederich M, Keane TJ, Sandoval P, Valente S, Strippoli R.

Front Pharmacol. 2020 Jan 16;10:1556. doi: 10.3389/fphar.2019.01556. eCollection 2019. No abstract available.

5.

Natural products target the hallmarks of chronic diseases.

Diederich M.

Biochem Pharmacol. 2020 Mar;173:113828. doi: 10.1016/j.bcp.2020.113828. Epub 2020 Jan 28.

PMID:
32001237
6.

Petromurin C Induces Protective Autophagy and Apoptosis in FLT3-ITD-Positive AML: Synergy with Gilteritinib.

Ha YN, Song S, Orlikova-Boyer B, Cerella C, Christov C, Kijjoa A, Diederich M.

Mar Drugs. 2020 Jan 16;18(1). pii: E57. doi: 10.3390/md18010057.

7.

Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells.

Grandjenette C, Schnekenburger M, Gaigneaux A, Gérard D, Christov C, Mazumder A, Dicato M, Diederich M.

Cancer Lett. 2020 Jan 28;469:468-480. doi: 10.1016/j.canlet.2019.11.017. Epub 2019 Nov 14.

PMID:
31734352
8.

Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemia.

Lernoux M, Schnekenburger M, Dicato M, Diederich M.

Biochem Pharmacol. 2020 Mar;173:113698. doi: 10.1016/j.bcp.2019.113698. Epub 2019 Nov 7. Review.

PMID:
31706847
9.

Inflammation regulates long non-coding RNA-PTTG1-1:1 in myeloid leukemia.

Chateauvieux S, Gaigneaux A, Gérard D, Orsini M, Morceau F, Orlikova-Boyer B, Farge T, Récher C, Sarry JE, Dicato M, Diederich M.

Haematologica. 2019 Oct 3. pii: haematol.2019.217281. doi: 10.3324/haematol.2019.217281. [Epub ahead of print]

10.

Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility.

Bellusci G, Mattiello L, Iannizzotto V, Ciccone S, Maiani E, Villani V, Diederich M, Gonfloni S.

Cell Death Dis. 2019 Sep 27;10(10):726. doi: 10.1038/s41419-019-1961-y.

11.

Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.

Menezes JCJMDS, Diederich MF.

Eur J Med Chem. 2019 Nov 15;182:111637. doi: 10.1016/j.ejmech.2019.111637. Epub 2019 Aug 22. Review.

PMID:
31494471
12.

Translational role of natural coumarins and their derivatives as anticancer agents.

Menezes JC, Diederich M.

Future Med Chem. 2019 May;11(9):1057-1082. doi: 10.4155/fmc-2018-0375. Epub 2019 May 29. Review.

PMID:
31140865
13.

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells.

Zwergel C, Schnekenburger M, Sarno F, Battistelli C, Manara MC, Stazi G, Mazzone R, Fioravanti R, Gros C, Ausseil F, Florean C, Nebbioso A, Strippoli R, Ushijima T, Scotlandi K, Tripodi M, Arimondo PB, Altucci L, Diederich M, Mai A, Valente S.

Clin Epigenetics. 2019 May 6;11(1):68. doi: 10.1186/s13148-019-0663-8.

14.

Natural compound inducers of immunogenic cell death.

Diederich M.

Arch Pharm Res. 2019 Jul;42(7):629-645. doi: 10.1007/s12272-019-01150-z. Epub 2019 Apr 6. Review.

PMID:
30955159
15.

Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?

Schnekenburger M, Dicato M, Diederich MF.

Cancer. 2019 May 15;125(10):1612-1628. doi: 10.1002/cncr.32041. Epub 2019 Mar 6. Review.

PMID:
30840315
16.

Personalized nutrition in ageing society: redox control of major-age related diseases through the NutRedOx Network (COST Action CA16112).

Tur JA, Jacob C, Chaimbault P, Tadayyon M, Richling E, Hermans N, Nunes Dos Santos C, Diederich M, Giblin L, Elhabiri M, Gaucher C, Andreoletti P, Fernandes A, Davies M, Bartoszek A, Cherkaoui-Malki M.

Free Radic Res. 2019;53(sup1):1163-1170. doi: 10.1080/10715762.2019.1572890. Epub 2019 Feb 22.

PMID:
30668224
17.

Isolation of anticancer and anti-trypanosome secondary metabolites from the endophytic fungus Aspergillus flocculus via bioactivity guided isolation and MS based metabolomics.

Tawfike AF, Romli M, Clements C, Abbott G, Young L, Schumacher M, Diederich M, Farag M, Edrada-Ebel R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Feb 1;1106-1107:71-83. doi: 10.1016/j.jchromb.2018.12.032. Epub 2019 Jan 6.

18.

Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis.

Florean C, Song S, Dicato M, Diederich M.

Free Radic Biol Med. 2019 Apr;134:177-189. doi: 10.1016/j.freeradbiomed.2019.01.008. Epub 2019 Jan 10. Review.

PMID:
30639617
19.

Natural modulators of the hallmarks of immunogenic cell death.

Radogna F, Dicato M, Diederich M.

Biochem Pharmacol. 2019 Apr;162:55-70. doi: 10.1016/j.bcp.2018.12.016. Epub 2019 Jan 5. Review.

PMID:
30615863
20.

Synergistic AML Cell Death Induction by Marine Cytotoxin (+)-1(R), 6(S), 1'(R), 6'(S), 11(R), 17(S)-Fistularin-3 and Bcl-2 Inhibitor Venetoclax.

Florean C, Kim KR, Schnekenburger M, Kim HJ, Moriou C, Debitus C, Dicato M, Al-Mourabit A, Han BW, Diederich M.

Mar Drugs. 2018 Dec 19;16(12). pii: E518. doi: 10.3390/md16120518.

Supplemental Content

Loading ...
Support Center